Inhibition of mutant Kras and p53-driven pancreatic carcinogenesis by atorvastatin: Mainly via targeting of the farnesylated DNAJA1 in chaperoning mutant p53.

Xu D, Tong X, Sun L, Li H, Jones RD, Liao J, Yang GY
Mol Carcinog. 2019 Nov;58(11):2052-2064. doi: 10.1002/mc.23097. Epub 2019 Aug 9. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.